Clinical Trial Update: Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients

View source ↗

Summary

A clinical trial evaluating a liver-specific oral contrast agent for MRI in metastatic colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Snippet

Sponsor: Copenhagen University Hospital at Herlev | Conditions: Neoplasm Metastasis, Liver | Status: WITHDRAWN